The main thing in a week in farme. On January 28 – on February 3

The number given-out Minzdrav permissions to carrying out clinical trials for last 2022 decreased, in comparison with previous year, for 18,5% – to 740. The tendency is caused by refusal of Big Pharma and other foreign sponsors of carrying out in our country of new KI. Foreign pharmaceutical companies initiated expensive international researches interesting to physicians. Activity of the Russian developers of loss will not compensate: researches of generics grow, and here original development at local sponsors each and all. It already influences tactics of KI providers – contract and research...